Systemic dermatological treatment with relevance for male fertility;Systemische dermatologische therapie mit relevanz für die männliche fertilität

JDDG - Journal of the German Society of Dermatology

Volumn 5, Issue 1, 2007, Pages 15-21

  Grunewald, Sonja ^a   Paasch, Uwe ^a   Glander, Hans Jürgen ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Andrology; Chemotherapy; Dermatology; Male fertility; Methotrexate; Retinoids; Spermatogenesis

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; BLEOMYCIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DACARBAZINE; DOXORUBICIN; FOTEMUSTINE; FUMARIC ACID; GLUCOCORTICOID; HYDROXYUREA; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERFERON; LOMUSTINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SALAZOSULFAPYRIDINE; TEMOZOLOMIDE; TUMOR NECROSIS FACTOR ALPHA; VINBLASTINE; VINCRISTINE; VINDESINE;

ASTHENOSPERMIA; AZOOSPERMIA; CYTOTOXICITY; EMBRYO DEVELOPMENT; ENTERITIS; FERTILITY; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE FERTILITY; MALE INFERTILITY; MELANOMA; NONHUMAN; OLIGOSPERMIA; PREDICTION; REPRODUCTIVE HEALTH; REVIEW; RISK ASSESSMENT; SPERMATOGENESIS; SPERMATOZOON; SPERMATOZOON ABNORMALITY;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; DERMATOLOGIC AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFERTILITY, MALE; MALE; RISK ASSESSMENT; SPERMATOZOA;

EID: 33846147018     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2007.06169.x     Document Type: Review

References (50)

1. Cooke GM, Newsome WH, Bondy GS, Arnold DL, Tanner JR, Robertson P, Whalen CM, Angers G, Masse A. The mammalian testis accumulates lower levels of organochlorine chemicals compared with other tissues. Reprod Toxicol 2001; 15: 333-338.
2. Howell SJ, Shalet SM. Effect of cancer therapy on pituitary-testicular axis. Int J Androl 2002; 25: 269-276.
3. Buchanan JD, Farley KF, Barrie JU. Return of spermatogenesis after stopping cyclophosphamide therapy. Lancet 1975; 26;2(7926):156-157.
4. Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. J Amer Med Ass 1988; 259: 2123-2125.
5. Blake DA, Heller RH, Hsu SH, Schacter BZ. Return of fertility in a patient with cyclophosphamide-induced azoospermia. John Hopkins Med J 1976; 139: 20-22.
6. Adler ID, Kliesch U, Jentsch I, Speicher MR. Induction of chromosomal aberrations by dacarbazine in somatic and germinal cells of mice. Mutagenesis 2002; 17: 383-389.
7. Palmieri C, Brock C, Newlands ES. Maintenance of fertility following treatment with temozolomide for a high grade astrocytoma. J Neurooncol 2005; 73: 185.
8. Cherry SM, Hunt PA, Hassold TJ. Cisplatin disrupts mammalian spermatogenesis, but does not affect recombination or chromosome segregation. Mutat Res 2004; 12: 115-128.
9. Fossa SD, Ous S, Abyholm T, Norman N, Loeb M. Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production. Br J Urol 1985; 57: 210-214.
10. Vawda AI. Effect of testosterone on cisplatin-induced testicular damage. Arch Androl 1994; 32: 53-57.
11. Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann R-D, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, MacKensen A, Kaufmann R. Malignes Melanom. In: Korting HC, Callies R, Reusch M, Schlaeger M, Sterry W: Dermatologische Qualitä tssicherung. Leitlinien und Empfehlungen. 4. Auflage. Berlin Leiben: ABW Wissenschaftsverlag, 2005: 202-234.
12. Brake A, Krause W. Treatment of idiopathic oligozoospermia with tamoxifen - a follow-up report. Int J Androl 1992; 15: 507-508.
13. Fahmy OG, Fahmy MJ. Hydroxylamine and derivatives: cytotoxicity without mutagenicity in cellular genetic systems. Chem Biol Interact 1970; 2: 331-348.
14. Meistrich ML, Wilson G, Mathur K, Fuller LM, Rodriguez MA, McLaughlin P, Romaguera JE, Cabanillas FF, Ha CS, Lipshultz LI, Hagemeister FB. Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease. J Clin Oncol 1997; 15: 3488-3495.
15. Todd GC, Gibson WR, Morton DM. Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogs. J Toxicol Environ Health 1976; 1: 843-850.
16. Longhi A, Macchiagodena M, Vitali G, Bacci G. Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma. J Pediatr Hematol Oncol 2003; 25: 292-296.
17. Nijman JM, Schraffordt Koops H, Kremer J, Sleijfer DT. Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors. J Clin Oncol 1987; 5: 651-656.
18. Pectasides D, Pectasides M, Farmakis D, Nikolaou M, Koumpou M, Kostopoulou V, Mylonakis N. Testicular function in patients with testicular cancer treated with bleomycinetoposide-carboplatin (BEC(90)) combination chemotherapy. Eur Urol 2004; 45: 187-193.
19. De Mas P, Daudin M, Vincent MC, Bourrouillou G, Calvas P, Mieusset R, Bujan L. Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin. Hum Reprod 2001; 16: 1204-1208.
20. Kubel Ch, Glander HJ. Testicular functions after bone marrow transplantation (long-term follow up analysis). Andrologia 1996; 28: 61-62.
21. Morris LF, Harrod MJ, Menter MA, Silverman AK. Methotrexate and reproduction in men: case report and recommendations. J Am Acad Dermatol 1993; 29: 913-916.
22. Sussman A, Leonard JM. Psoriasis, methotrexate, and oligospermia. Arch Dermatol 1980; 116: 215-217.
23. Schrader M, Muller M, Straub B, Miller K. The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reprod Toxicol 2001; 15: 611-617.
24. Ligumsky M, Badaan S, Lewis H, Meirow D. Effects of 6-mercaptopurine treatment on sperm production and reproductive performance: a study in male mice. Scand J Gastroenterol 2005; 40: 444-449.
25. Dejaco C, Mittermaier C, Reinisch W, Gasche C, Waldhoer T, Strohmer H, Moser G. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001; 121: 1048-1053.
26. O'Morain C, Smethurst P, Dore CJ, Levi AJ. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984; 25: 1078-1084.
27. Steeno OP. Side-effects of salazopyrin on male fertility. Eur J Obstet Gynecol Reprod Biol 1984; 18: 361-364.
28. Niederberger C. The adverse effect of sulfasalazine on spermatogenesis and male reproductive potential. J Androl 2002; 23: 180.
29. Fukushima T, Kato M, Adachi T, Hamada Y, Horimoto M, Komiyama M, Mori C, Horii I. Effects of sulfasalazine on sperm acrosome reaction and gene expression in the male reproductive organs of rats. Toxicol Sci 2005; 85: 675-682.
30. Srinivas M, Agarwala S, Datta Gupta S, Das SN, Jha P, Misro MM, Mitra DK. Effect of cyclosporine on fertility in male rats. Pediatr Surg Int 1998; 13: 388-391.
31. Iwasaki M, Fuse H, Katayama T. Histological and endocrinological investigations of cyclosporine effects on the rat testis. Andrologia 1995; 27: 185-189.
32. Haberman J, Karwa G, Greenstein SM, Soberman R, Glicklich D, Tellis V, Melman A. Male fertility in cyclosporine-treated renal transplant patients. J Urol 1991; 145: 294-296.
33. Naz RK. Modalities for treatment of antisperm antibody mediated infertility: novel perspectives. Am J Reprod Immunol 2004; 51: 390-397.
34. Comitato R, Esposito T, Cerbo G, Angelini F, Varriale B, Cardone A. Impairment of spermatogenesis and enhancement of testicular germ cell apoptosis induced by exogenous alltrans-retinoic acid in adult lizard Podarcis sicula. J Exp Zoolog A Comp Exp Biol 2006; 305: 288-298.
35. Parsch EM, Ruzicka T, Przybilla B, Schill WB. Andrological investigations in men treated with acitretin (Ro 10-1670). Andrologia 1990; 22: 479-482.
36. Geiger JM, Walker M. Is there a reproductive safety risk in male patients treated with acitretin (neotigason/soriatane)? Dermatology 2002; 205: 105-107.
37. Naz RK, Chauhan SC, Rose LP. Expression of alpha and gamma interferon receptors in the sperm cell. Mol Reprod Dev 2000; 56: 189-197.
38. Karamfilov T, Wollina U, Hipler UC, Graefe T, Schreiber G. Effects of adjuvant interferon-alpha low-dose therapy in melanoma patients on serum inhibin B. J Dermatol 2000; 27: 639-642.
39. Trotter JF, Zygmunt AJ. Conception and pregnancy during interferon-alpha therapy for chronic hepatitis C. J Clin Gastroenterol 2001; 32: 76-78.
40. Yamamoto M, Miyake K. Successful use of interferon for male infertility. Lancet 1994; 344(8922): 614.
41. Ku JH, Kim YH, Jeon YS, Lee NK. The preventive effect of systemic treatment with interferon-alpha2B for infertility from mumps orchitis. BJU Int 1999; 84: 839-842.
42. Adeeko AO, Dada OA. Chloroquine excretion in semen following antimalarial-drug administration. Andrologia 1994; 26: 165-166.
43. Hargreaves CA, Rogers S, Hills F, Rahman F, Howell RJ, Homa ST. Effects of co-trimoxazole, erythromycin, amoxycillin, tetracycline and chloroquine on sperm function in vitro. Hum Reprod 1998; 13: 1878-1886.
44. Mogilner JG, Elenberg Y, Lurie M, Shiloni E, Coran AG, Sukhotnik I. Effect of dexamethasone on germ cell apoptosis in the contralateral testis after testicular ischemia-reperfusion injury in the rat. Fertil Steril 2006; 85 Suppl 1: 1111-1117.
45. Xiong Y, Hales DB. Expression, regulation, and production of tumor necrosis factor-alpha in mouse testicular interstitial macrophages in vitro. Endocrinology 1993; 133: 2568-2573.
46. Said TM, Agarwal A, Falcone T, Sharma RK, Bedaiwy MA, Li L. Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro model. Fertil Steril 2005; 83: 1665-1673.
47. Meseguer M, Molina N, Garcia-Velasco JA, Remohi J, Pellicer A, Garrido N. Sperm cryopreservation in oncological patients: a 14-year follow-up study. Fertil Steril 2006; 85: 640-645.
48. Dondero F, Glander HJ. Standards for sperm banking. Cell and Tissue Banking 2000; 1: 87-90.
49. Lansac J, Royere D. Follow-up studies of children born after frozen sperm donation. Hum Reprod Update 2001; 7: 33-37.
50. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005; 6: 209-218.